CalliSpheres drug-eluting beads versus lipiodol transarterial chemoembolization in the treatment of hepatocellular carcinoma: a short-term efficacy and safety study

Table 4 Liver enzymes and AFP levels changes before and after treatment

Variables	DEB-TACE (n = 24)			cTACE (n = 30)			DEB-TACE vs cTACE^c
Variables	Before TACE	1 week after TACE^a	1 month after TACE^b	Before TACE	1 week after TACE^a	1 month after TACE^b	t value	p value
ALB (g/L)	40.64 ± 4.77	34.07 ± 4.42	38.23 ± 3.83	39.64 ± 4.33	34.45 ± 3.74	37.52 ± 4.05	0.654	0.516
TP (g/L)	66.32 ± 7.32	61.06 ± 5.27	65.55 ± 5.62	67.03 ± 4.23	59.11 ± 4.35	64.31 ± 3.05	1.037	0.304
ALT (U/L)	38.17 ± 22.92	58.38 ± 38.08	40.50 ± 22.23	38.04 ± 15.71	65.92 ± 30.83	56.75 ± 30.80	− 2.057	0.045
AST (U/L)	44.58 ± 25.06	63.00 ± 25.52	45.67 ± 15.51	45.47 ± 32.53	73.87 ± 47.64	60.77 ± 32.30	− 2.102	0.040
TBil (umol/L)	16.11 ± 4.28	30.33 ± 18.06	16.85 ± 4.24	16.29 ± 4.63	29.59 ± 16.61	20.87 ± 8.47	− 2.124	0.038
AFP (ng/ml)	1197.41 ± 628.81	566.22 ± 217.99	158.06 ± 69.89	1144.69 ± 444.35	604.91 ± 250.00	221.00 ± 109.12	− 2.748	0.008

ISSN: 1477-7819